Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan-Mar;33(1):10-16.
doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29.

Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis

Affiliations
Review

Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis

Caterina Oriana Aragona et al. J Cardiovasc Echogr. 2023 Jan-Mar.

Abstract

Coronavirus disease 2019 (COVID-19) is characterized by multi-organ involvement, including respiratory and cardiac events. Echocardiography is widely considered the first-choice tool for the evaluation of cardiac structures and function because of its reproducibility, feasibility, easy to use at bedside, and for good cost-effectiveness. The aim of our literature review is to define the utility of echocardiography in the prediction of prognosis and mortality in COVID-19 patients with mild to critical respiratory illness, with or without known cardiovascular disease. Moreover, we focused our attention on classical echocardiographic parameters and the use of speckle tracking to predict the evolution of respiratory involvement. Finally, we tried to explore the possible relationship between pulmonary disease and cardiac manifestations.

Keywords: Cardiovascular diseases; coronavirus disease 2019; respiratory failure; severe acute respiratory syndrome coronavirus 2; speckle tracking; transthoracic echocardiography.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Chilamakuri R, Agarwal S. COVID-19: Characteristics and therapeutics. Cells. 2021;10:206. - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Bagnato G, La Rosa D, Ioppolo C, De Gaetano A, Chiappalone M, Zirilli N, et al. The COVID-19 assessment for survival at admission (CASA) index: A 12 months observational study. Front Med (Lausanne) 2021;8:719976. - PMC - PubMed
    1. Mann CZ, Abshire C, Yost M, Kaatz S, Swaminathan L, Flanders SA, et al. Derivation and external validation of a simple risk score to predict in-hospital mortality in patients hospitalized for COVID-19: A multicenter retrospective cohort study. Medicine (Baltimore) 2021;100:e27422. - PMC - PubMed
    1. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article –Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020;63:682–9. - PMC - PubMed